PMU19 FIRST LINE TREATMENT WITH NATALIZUMAB REDUCES HEALTHCARE RESOURCE USE AND IMPAIRMENT OF WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) PATIENTS COMPARED TO NATALIZUMAB DELAYED USE
May 1, 2020, 00:00
10.1016/j.jval.2020.04.795
https://www.valueinhealthjournal.com/article/S1098-3015(20)30983-9/fulltext
Title :
PMU19 FIRST LINE TREATMENT WITH NATALIZUMAB REDUCES HEALTHCARE RESOURCE USE AND IMPAIRMENT OF WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) PATIENTS COMPARED TO NATALIZUMAB DELAYED USE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30983-9&doi=10.1016/j.jval.2020.04.795
First page :
Section Title :
Open access? :
No
Section Order :
10698